A phase II trial of lenalidomide plus rituximab in previously untreated follicular non-Hodgkin’s lymphoma (NHL): CALGB 50803 (Alliance)

Peter W. Martin(Cornell University), Bruce D. Cheson(Georgetown University)
Annals of Oncology
August 30, 2017
Cited by 82


Related Papers